Publications

Value Health.

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

26-01-2023

J Mol Diagn.

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

25-01-2023

N Engl J Med

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

08-12-2022

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Organization of head and neck cancer rehabilitation care: a national survey among healthcare professionals in Dutch head and neck cancer centers.

01-05-2024

JMIR research protocols

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.

18-04-2024

The Lancet. Oncology

The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.

01-04-2024

Journal for immunotherapy of cancer

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

26-03-2024

International journal of cancer

Differences in time to patient access to innovative cancer medicines in six European countries.

01-03-2024

PharmacoEconomics - open

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis.

01-01-2024

Molecular oncology

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

07-12-2023

Gynecologic oncology reports

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer.

01-12-2023

BMC cancer

Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.

14-11-2023

European journal of cancer (Oxford, England : 1990)

Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.

01-10-2023

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Health-state utilities in long-term advanced melanoma survivors comparable with the general population.

01-09-2023

Journal of cancer survivorship : research and practice

"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care.

22-08-2023

Drug discovery today

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

01-08-2023

European journal of cancer (Oxford, England : 1990)

Duty to recontact in genomic cancer care: A tool helping to assess the professional's responsibility.

01-06-2023

Radiology

Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.

01-04-2023

Frontiers in oncology

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

28-03-2023

BMJ open

EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.

07-03-2023

BMC cancer

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.

07-01-2023

The Journal of molecular diagnostics : JMD

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

01-01-2023

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.

01-01-2023

The New England journal of medicine

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

08-12-2022

European journal of cancer (Oxford, England : 1990)

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

01-11-2022

Gynecologic oncology

Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.

01-06-2022

Scientific reports

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes.

10-05-2022

BMC cancer

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

06-05-2022

Cancers

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

31-03-2022

BMC medical research methodology

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.

27-03-2022

International journal of health policy and management

Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.

01-03-2022

Nederlands tijdschrift voor geneeskunde

[Clinical efficiency research with expensive drugs: doing more with less investment].

15-02-2022

Cancer discovery

Improving the Affordability of Anticancer Medicines Demands Evidence-Based Policy Solutions.

01-02-2022

Cancer research communications

Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations.

01-01-2022

PharmacoEconomics

Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

01-12-2021

BMC public health

Supporting participation in paid work of cancer survivors and their partners in the Netherlands: protocol of the SusTained Employability in cancer Patients and their partnerS (STEPS) multi-centre randomized controlled trial and cohort study.

12-10-2021

Annals of oncology : official journal of the European Society for Medical Oncology

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.

01-10-2021

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Long-term functional outcomes after robot-assisted prostatectomy compared to laparoscopic prostatectomy: Results from a national retrospective cluster study.

01-10-2021

Cancers

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.

06-08-2021

Medical decision making : an international journal of the Society for Medical Decision Making

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy.

01-08-2021

Cancers

Effects of and Lessons Learned from an Internet-Based Physical Activity Support Program (with and without Physiotherapist Telephone Counselling) on Physical Activity Levels of Breast and Prostate Cancer Survivors: The PABLO Randomized Controlled Trial.

21-07-2021

Expert review of pharmacoeconomics & outcomes research

Early technology assessment of using whole genome sequencing in personalized oncology.

01-06-2021

Expert review of pharmacoeconomics & outcomes research

Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.

01-06-2021

Breast cancer research and treatment

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?

01-05-2021

BMC cancer

Whole genome sequencing in oncology: using scenario drafting to explore future developments.

01-05-2021

BMC cancer

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.

26-04-2021

The Journal of molecular diagnostics : JMD

Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.

01-04-2021

Journal of cancer policy

Securing sustainable price levels of innovative anticancer drugs: How to move forward?

01-03-2021

The Laryngoscope

Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer.

01-02-2021

The Journal of surgical research

Selecting Image-Guided Surgical Technologies in Oncology: A Surgeon's Perspective.

01-01-2021

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Organization of head and neck cancer rehabilitation care: a national survey among healthcare professionals in Dutch head and neck cancer centers.

Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.

The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions.

Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial.

Differences in time to patient access to innovative cancer medicines in six European countries.

Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis.

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Health state utility and health-related quality of life measures in patients with advanced ovarian cancer.

Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design.

Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial.

Health-state utilities in long-term advanced melanoma survivors comparable with the general population.

"One more chance to survive": the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy-a qualitative study and recommendations for future care.

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

Duty to recontact in genomic cancer care: A tool helping to assess the professional's responsibility.

Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ.

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC).

EffectiveNess of a multimodal preHAbilitation program in patieNts with bladder canCEr undergoing radical cystectomy: protocol of the ENHANCE multicentre randomised controlled trial.

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer.

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma.

Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancer.

Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes.

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.

Understanding the Costs of Surgery: A Bottom-Up Cost Analysis of Both a Hybrid Operating Room and Conventional Operating Room.

[Clinical efficiency research with expensive drugs: doing more with less investment].

Improving the Affordability of Anticancer Medicines Demands Evidence-Based Policy Solutions.

Affordable Prices Without Threatening the Oncological R&D Pipeline-An Economic Experiment on Transparency in Price Negotiations.

Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer.

Supporting participation in paid work of cancer survivors and their partners in the Netherlands: protocol of the SusTained Employability in cancer Patients and their partnerS (STEPS) multi-centre randomized controlled trial and cohort study.

A revolving research fund to study efficient use of expensive drugs: big wheels keep on turning.

Long-term functional outcomes after robot-assisted prostatectomy compared to laparoscopic prostatectomy: Results from a national retrospective cluster study.

Preferences of Treatment Strategies among Women with Low-Risk DCIS and Oncologists.

Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy.

Effects of and Lessons Learned from an Internet-Based Physical Activity Support Program (with and without Physiotherapist Telephone Counselling) on Physical Activity Levels of Breast and Prostate Cancer Survivors: The PABLO Randomized Controlled Trial.

Early technology assessment of using whole genome sequencing in personalized oncology.

Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing.

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?

Whole genome sequencing in oncology: using scenario drafting to explore future developments.

Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.

Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals.

Securing sustainable price levels of innovative anticancer drugs: How to move forward?

Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer.

Selecting Image-Guided Surgical Technologies in Oncology: A Surgeon's Perspective.

This site uses cookies